JavaScript is disabled! Why you want to do so? Please enable JavaScript in your web browser!
This feat marks a decisive step for medicine in Morocco, opening new perspectives of access to specialized care, even in the most remote regions, indicates a press release from Oncorad Group.
This complex intervention, carried out remotely to treat a localized prostate canceris based on cutting-edge telesurgery technology. Total prostatectomy consists of the complete removal of the prostate gland, an essential operation in the control and treatment of this pathology, explains the group. This type of procedure is often recommended for patients for whom complete ablation offers the best chance of remission.
By accomplishing this operation from an unprecedented distance, Oncorad Group demonstrates the capability of telesurgery to overcome geographical constraints, thus offering effective treatment to patients, even in remote regions, continues the same source.
The success of this operation relies on the use of the surgical robot Toumaiassociated with an advanced communications platform allowing real-time transmission of surgeon commands with absolute precision and high-definition 3D images.
The operation was led by Dr Younis Ahallalurological surgeon and expert in robotic and cancer surgery, present in Shanghai and supported by a team on site in Morocco including Dr Hamza Neil, patient’s referring urological surgeon, Dr Oskar Blezien, assistant urological surgeon, Dr Adil Mellouki, assistant professor in urology , Dr Anas Bakka and Dr Kamal Belkadi anesthetists, as well as specialist nurses from Oncorad Group to manage the local aspects of the procedure.
Technical supervision and maintenance of the equipment were carried out by a team of qualified Moroccan biomedical engineers. The telecoms operator Orange Maroc was the partner of Oncorad Group, providing several innovative solutions to guarantee the safety and success of the surgical intervention, specifies the press release. Orange Maroc has deployed very high-speed connectivity with guaranteed speed, ultra-low latency and on two technologies in parallel in order to ensure the resilience necessary for this type of operations.
The confidentiality of patient data was protected using advanced encryption protocols and sophisticated firewalls, continues the same source.
Dr Ahallal joins the Oncorad team of specialists
In a separate press release, Oncorad Group announced that Dr. Youness Ahallal, an internationally renowned urological surgeon and onco-urologist, will now be part of Oncorad’s team of specialists.
An expert in robotic surgery, Dr. Ahallal brings a rich and diverse experience acquired within leading institutions, such as the Memorial Sloan Kettering Cancer Center in New York, the Institut Mutualiste Montsouris in Paris, and the University Hospital of Nice, where he currently teaches robotic surgery, the release said.
Specializing in the minimally invasive surgical treatment of genitourinary pathologies, with a particular focus on urological cancers, Dr Ahallal will contribute to strengthening the group’s skills in terms of innovation and cutting-edge technologies, underlines the same source.
The arrival of Dr Ahallal is fully in line with Oncorad Group’s commitment to developing and integrating robotic surgery into its medical practices, with the aim of offering its patients more precise, less invasive and always cutting-edge care. scientific advances, underlines the group.
Author of numerous publications in international scientific journals, Dr Ahallal was also a trainer in minimally invasive surgery at the European School of Surgery of the University of Paris 5 and at the Fer à Moulin School of Surgery in Paris.
Do you have a real estate project in mind? Yakeey & Médias24 help you make it happen!
© Media24. Any reproduction prohibited, in any form whatsoever, without written authorization from the Société des Nouveaux Médias. This content is protected by law and in particular law 88-13 relating to the press and publishing as well as laws 66.19 and 2-00 relating to copyright and related rights.
November 19, 2024 at 11:30 a.m.
Modified November 19, 2024 at 12:04 p.m.
Related News :